Procurement of Essential Injectable Pharmaceuticals for Indian Army Healthcare

This tender, originating from the Department of Military Affairs under the Ministry of Defence and managed by the Indian Army, represents a significant procurement opportunity for a comprehensive range of essential injectable pharmaceuticals. The bid, identified by Bid Number GEM/2026/B/8237013, is open for submissions from November 4, 2026, at 10:21 AM until November 14, 2026, at 11:00 AM. The procurement encompasses a substantial total quantity of 2329 units across a diverse array of medications, including but not limited to, anesthetic agents like Propofol, Bupivacaine (Heavy and HCl), and Ketamine; emergency and critical care drugs such as Atropine Sulphate, Midazolam, Ondansetron, Adenosine, Amiodorone, Dobutamine, Enoxaparin, Metoclopramide, Hyoscine Bromide, Vecuronium Bromide, Atracurium, and Vasopressin; critical electrolyte and fluid management solutions including Dextrose 25, Potassium Chloride, Sodium Bicarbonate, and Sodium Chloride; antibiotics like Amoxycillin-Clavulanic Acid and Amikacin Sulphate; essential vitamins and nutritional supplements such as B12, Calcium Gluconate, Multi Vitamin, and Neurobion Forte; pain management and supportive therapies including Paracetamol, Tramadol HCl, Adrenaline Tartrate, Dexamethasone Sodium Phosphate, Pheniramine Maleate, Nor adrenaline Bitartrate, and Diazepam; and vital vaccines and immunoglobulins, specifically Purified Vero Cell Rabies Vaccine and Human Rabies Immunoglobulin. This broad spectrum of medical supplies underscores the critical need for reliable and high-quality pharmaceutical vendors to support the healthcare requirements of the Indian Army.